In one research, Smad7 antisense oligonucleotide treatment alleviated colitis along with reduced collagen deposition and stopped fibrosis in mice, which was associated with lower TGF-β1 production and p-Smad3 protein expression [74]. This evidence concerns the gene TGFB1 and colitis.